neurotensin (8-13) has been researched along with gzr 123 in 1 studies
Studies (neurotensin (8-13)) | Trials (neurotensin (8-13)) | Recent Studies (post-2010) (neurotensin (8-13)) | Studies (gzr 123) | Trials (gzr 123) | Recent Studies (post-2010) (gzr 123) |
---|---|---|---|---|---|
66 | 0 | 10 | 22 | 1 | 11 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cherniakova, IV; Gudasheva, TA; Klodt, PM; Kolik, LG; Konstantinopol'skiĭ, MA; Kudrin, VS | 1 |
1 other study(ies) available for neurotensin (8-13) and gzr 123
Article | Year |
---|---|
[Neurotensin NT (8- 13) dipeptide analog dilept increases the pain threshold and decreases the severity of morphine withdrawal syndrome in rats].
Topics: Animals; Dopamine; Frontal Lobe; Hypothalamus; Male; Morphine; Naloxone; Narcotic Antagonists; Narcotics; Neurotensin; Pain; Pain Threshold; Peptide Fragments; Proline; Rats; Serotonin; Severity of Illness Index; Substance Withdrawal Syndrome; Tyrosine | 2013 |